a16z Podcast: Damage-free Genome Editing -- Next in CRISPR

2019-06-26 · 15 min · episode 463 · 13 entities

episode page audio

Asserted relationships

→ hosted by Andreessen Horowitz person

0.55

evidence rules-v4
Feed author/publisher: Andreessen Horowitz
→ discusses Science concept

0.40

evidence rules-v4
Feed category: Science
→ discusses Technology concept

0.40

evidence rules-v4
Feed category: Technology
→ discusses Business concept

0.40

evidence rules-v4
Feed category: Business
→ discusses Entrepreneurship concept

0.40

evidence rules-v4
Feed category: Entrepreneurship
→ hosted by a16z company

0.40

evidence rules-v4
Feed author/publisher: a16z

Entities found in this episode

concepts 10

mentioned Science concept

0.50

evidence rules-v4
Feed category: Science
mentioned Technology concept

0.50

evidence rules-v4
Feed category: Technology
mentioned Business concept

0.50

evidence rules-v4
Feed category: Business
mentioned Entrepreneurship concept

0.50

evidence rules-v4
Feed category: Entrepreneurship
mentioned Damage-free Genome Editing -- Next in CRISPR concept

0.42

evidence rules-v4
a16z Podcast: Damage-free Genome Editing -- Next in CRISPR
discusses Science concept

0.40

evidence rules-v4
Feed category: Science
discusses Technology concept

0.40

evidence rules-v4
Feed category: Technology
discusses Business concept

0.40

evidence rules-v4
Feed category: Business
discusses Entrepreneurship concept

0.40

evidence rules-v4
Feed category: Entrepreneurship
mentioned CRISPR concept

0.35

evidence rules-v4
CRISPR

persons 2

mentioned Andreessen Horowitz person

0.70

evidence rules-v4
Feed author/publisher: Andreessen Horowitz
hosted by Andreessen Horowitz person

0.55

evidence rules-v4
Feed author/publisher: Andreessen Horowitz

companys 1

hosted by a16z company

0.40

evidence rules-v4
Feed author/publisher: a16z

Episode description as stored

Two recent scientific journal papers show what's possible when CRISPR moves from cutting DNA tool to a full-fledged platform -- expanding its toolkit for medicine across R&D, therapeutics, and diagnostics: "Transposon-encoded CRISPR-Cas systems direct RNA-guided DNA integration" in Nature -- by Sanne Klompe, Phuc Vo, Tyler Halpin-Healy, and Samuel Sternberg (of Columbia University) "RNA-guided DNA insertion with CRISPR-associated transposases" in Science -- by Jonathan Strecker, Alim Ladha, Zachary Gardner, Jonathan Schmid-burgk, Kira Makarova, Eugene Koonin, and Feng Zhang (of the Broad Institute) What do these two papers -- both about techniques for getting rid of the need to cut the genome to edit it -- make possible going forward, given the ongoing shift of biology becoming more like engineering? Where are we in the wave of the genome engineering "developer community" building on top of CRISPR with a constantly growing suite of programmable functionalities? a16z bio general partner Jorge Conde and bio deal team partner Andy Tran chat with Hanne Tidnam about these trends -- and these two papers -- in this short internal hallway-style conversation, part of our new a16z Journal Club series. This podcast is also part of our new a16z bio newsletter, which you can sign up for at a16z.com/subscribe Stay Updated: Find a16z on YouTube: YouTube Find a16z on X Find a16z on LinkedIn Listen to the a16z Show on Spotify Listen to the a16z Show on Apple Podcasts Follow our host: https://twitter.com/eriktorenberg Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.